Page last updated: 2024-12-08

asperflavin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

asperflavin: metabolic product of Aspergillus flavus [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14355112
CHEMBL ID3358707
SCHEMBL ID16225648
MeSH IDM0043054

Synonyms (14)

Synonym
ACON1_000647
NCGC00169497-01
BRD-K61109077-001-01-6
asperflavin
6E7PB8M04P ,
1(2h)-anthracenone, 3,4-dihydro-3,6,9-trihydroxy-8-methoxy-3-methyl-, (3s)-
unii-6e7pb8m04p
1415764-41-8
SCHEMBL16225648
CHEMBL3358707
Q27264670
(3s)-3,6,9-trihydroxy-8-methoxy-3-methyl-2,4-dihydroanthracen-1-one
asperflavine
AKOS040734974
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1174113Antimycobacterial activity against Mycobacterium tuberculosis H37Ra after 7 days by microplate Alamar blue assay2015European journal of medicinal chemistry, Jan-07, Volume: 89Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]